
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
“`html Study on Bipolar Disorder Medication and Physical Disorders Key Findings: Bipolar disorder is linked to higher rates of physical disorders. Study compared the effects of lithium, lamotrigine, and valproate…
Understanding the Study Results on Electroconvulsive Therapy (ECT) This study looked at how a new type of ECT, called ultra-brief pulse ECT, affects patients with schizophrenia, especially regarding the risk…
Understanding the PRO-TECT Trial Results The PRO-TECT trial looked at how patients report their symptoms during cancer treatment. It offered two ways for patients to share their health updates: through…
Introduction Irritable bowel syndrome (IBS) is a common condition affecting the gut and brain. Currently, there is no specific treatment for IBS. Factors like low-grade inflammation and oxidative stress may…
Understanding the IMAGINE Trial Results The IMAGINE trial aimed to test a new way to help teenagers dealing with depression in schools. This trial is important because it focuses on…
Understanding the Study This study looked at how one session of strength training, either in-person or online, affects low back pain and disability in pregnant women. It also checked how…
“`html Background People with advanced cancer often struggle with sleep problems. These issues can lead to bad moods, a lower quality of life, and even shorter survival times. Many patients…